,drug_name,section_name,gpt_output
0,KYPROLIS,adverse reactions,"Cardiac Toxicities, Acute Renal Failure, Tumor Lysis Syndrome, Pulmonary Toxicity, Pulmonary Hypertension, Dyspnea, Hypertension, Venous Thrombosis, Infusion Reactions, Thrombocytopenia, Hepatic Toxicity, Hepatic Failure, Thrombotic Thrombocytopenic Purpura, Hemolytic Uremic Syndrome, Posterior Reversible Encephalopathy Syndrome, Anemia, Fatigue, Thrombocytopenia, Nausea, Pyrexia, Decreased Platelets, Diarrhea, Decreased Lymphocyte, Headache, Decreased Hemoglobin, Cough, Edema Peripheral, Neutropenia, Decreased Phosphorus, Muscle Spasm, Upper Respiratory Tract Infection, Hypokalemia, Pneumonia, Constipation, Nasopharyngitis, Bronchitis, Rash, Embolic and Thrombotic Events, Venous, Febrile Neutropenia, Lymphopenia, Cardiac Arrest, Cardiac Failure, Cardiac Failure Congestive, Myocardial Infarction, Myocardial Ischemia, Cataract, Vision Blurred, Abdominal Pain, Abdominal Pain Upper, Dyspepsia, Toothache, Chills, Multi-organ Failure, Pain, Influenza, Sepsis, Urinary Tract Infection, Viral Infection, Dehydration, Hyperkalemia, Hyperuricemia, Hypoalbuminemia, Hyponatremia, Muscular Weakness, Myalgia, Hypoesthesia, Paresthesia, Deafness, Anxiety, Delirium, Renal Failure, Renal Failure Acute, Renal Impairment, Dysphonia, Epistaxis, Oropharyngeal Pain, Pulmonary Embolism, Pulmonary Edema, Erythema, Hyperhidrosis, Pruritus, Deep Vein Thrombosis, Hypotension, Death."
1,KYPROLIS,warnings and precautions,"cardiac failure, myocardial infarction, death, myocardial ischemia, acute renal failure, tumor lysis syndrome, pulmonary toxicity, acute respiratory distress syndrome, acute respiratory failure, acute diffuse infiltrative pulmonary disease, pulmonary hypertension, dyspnea, hypertension, hypertensive crisis, venous thrombosis, infusion reactions, thrombocytopenia, hepatic toxicity, hepatic failure, thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, posterior reversible encephalopathy syndrome, embryo-fetal toxicity"
2,MULTAQ,adverse reactions,"heart failure, liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, QT prolongation, diarrhea, nausea, abdominal pain, vomiting, asthenia, bradycardia, rashes, pruritus, eczema, dermatitis, dermatitis allergic, photosensitivity reaction, dysgeusia, atrial flutter, interstitial lung disease, pneumonitis, pulmonary fibrosis, anaphylactic reactions, angioedema, vasculitis, leukocytoclastic vasculitis"
3,MULTAQ,boxed warnings,"death, stroke, heart failure, hospitalization"
4,MULTAQ,warnings and precautions,"cardiovascular death, death, heart failure, arrhythmic death, heart failure events, stroke, new onset heart failure, worsening heart failure, liver injury, acute liver failure, liver transplant, pulmonary toxicity, interstitial lung disease, pneumonitis, pulmonary fibrosis, hypokalemia, hypomagnesemia, QT interval prolongation, renal impairment, renal failure, fetal harm"
5,JUBLIA,adverse reactions,"ingrown toenails, application site dermatitis, application site vesicles, application site pain"
6,TEFLARO,adverse reactions,"hypersensitivity reactions, clostridium difficile-associated diarrhea, direct coombs' test seroconversion, diarrhea, nausea, rash, death, constipation, vomiting, increased transaminases, hypokalemia, phlebitis, anemia, eosinophilia, neutropenia, thrombocytopenia, bradycardia, palpitations, abdominal pain, pyrexia, hepatitis, anaphylaxis, clostridium difficile colitis, hyperglycemia, hyperkalemia, dizziness, convulsion, renal failure, urticaria, agranulocytosis"
7,TEFLARO,warnings and precautions,"hypersensitivity reactions, anaphylactic reactions, serious skin reactions, Clostridium difficile-associated diarrhea, CDAD, fatal colitis, Direct Coombs' test seroconversion, drug-induced hemolytic anemia, death"
8,DATSCAN,adverse reactions,"hypersensitivity, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness"
9,DATSCAN,warnings and precautions,"hypersensitivity reactions, anaphylactic reactions, skin erythema, pruritis, corticosteroids, anti-histamines, thyroid accumulation, iodine 123, thyroid neoplasia"
10,TIVICAY,adverse reactions,"Hypersensitivity reactions, Effects on serum liver biochemistries, Fat Redistribution, Immune Reconstitution Syndrome, death, Insomnia, Fatigue, Headache, Depression, Abnormal dreams, Dizziness, Nausea, Diarrhea, Rash, Vertigo, Abdominal pain, Abdominal discomfort, Flatulence, Upper abdominal pain, Vomiting, Hepatitis, Myositis, Suicidal ideation, Suicidal attempt, Suicidal behavior, Suicidal completion, Renal impairment, Pruritus, Elevated ALT, Elevated AST, Hyperglycemia, Elevated lipase, Elevated cholesterol, Elevated creatine kinase, Neutropenia."
11,TIVICAY,warnings and precautions,"rash, constitutional findings, organ dysfunction, liver injury, transaminase elevations, hepatotoxicity, redistribution/accumulation of body fat, immune reconstitution syndrome, central obesity, dorsocervical fat enlargement, peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome, death"
12,TAFINLAR,adverse reactions,"New Primary Malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, death, hyperkeratosis, headache, pyrexia, arthralgia, papilloma, alopecia, palmar-plantar erythrodysesthesia syndrome, chills, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, peripheral edema, cough, night sweats, decreased appetite, constipation, myalgia, back pain, nasopharyngitis, pancreatitis, hypersensitivity manifesting as bullous rash, interstitial nephritis, squamous cell carcinoma of the skin, keratoacanthoma, cough, dry skin, dermatitis acneiform, actinic keratosis, erythema, pruritus, dizziness, oropharyngeal pain, muscle spasms, pain in extremity, dehydration, insomnia, hypertension, urinary tract infection, renal failure, vision blurred, transient blindness, stomatitis, asthenia, cellulitis, folliculitis, paronychia, rash pustular, hyperhidrosis."
13,TAFINLAR,warnings and precautions,"Retinal vein occlusion, Interstitial lung disease, death, New primary malignancies, cutaneous and non-cutaneous, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, death, Venous Thromboembolism, death, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, Embryofetal Toxicity"
14,HORIZANT,adverse reactions,"somnolence, sedation, dizziness, death, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, weight increased, increased appetite, vertigo, depression, libido decreased, balance disorder, blurred vision, disorientation, lethargy, breast enlargement, gynecomastia, elevated creatine kinase, insomnia, confusional state."
15,HORIZANT,warnings and precautions,"driving impairment, somnolence, sedation, dizziness, suicidal thoughts, suicidal behaviors, death, drug reaction with eosinophilia and systemic symptoms (DRESS), multiorgan hypersensitivity"
16,IMBRUVICA,adverse reactions,"Hemorrhage, Infections, Cytopenias, Atrial Fibrillation, Second Primary Malignancies, Tumor Lysis Syndrome, death, thrombocytopenia, neutropenia, diarrhea, anemia, fatigue, musculoskeletal pain, bruising, nausea, upper respiratory tract infection, rash, pneumonia, abdominal pain, atrial fibrillation, constipation, dyspnea, vomiting, decreased appetite, skin infections, urinary tract infection, sinusitis, peripheral edema, pyrexia, asthenia, muscle spasms, arthralgia, cough, epistaxis, dehydration, dizziness, headache, lymphocytosis, intracranial hemorrhage, lethargy, gait instability, hyperuricemia, subdural hematoma, urticaria, angioedema."
17,IMBRUVICA,warnings and precautions,"Hemorrhage, bleeding, subdural hematoma, gastrointestinal bleeding, hematuria, post procedural hemorrhage, bruising, petechiae, death, Infections, fatal infections, progressive multifocal leukoencephalopathy, Cytopenias, neutropenia, thrombocytopenia, anemia, Atrial Fibrillation, atrial flutter, Second Primary Malignancies, non-skin carcinomas, non-melanoma skin cancer, Tumor Lysis Syndrome, Embryo-Fetal Toxicity, fetal harm, malformations, reduced fetal weights."
18,ULORIC,adverse reactions,"liver function abnormalities, nausea, arthralgia, rash, death"
19,ULORIC,warnings and precautions,"Gout Flare, Cardiovascular Events, Hepatic Effects, death"
20,CIMZIA,adverse reactions,"upper respiratory tract infection, rash, urinary tract infection, serious infections, malignancies, heart failure, Crohn's disease, rheumatoid arthritis, abdominal pain, diarrhea, intestinal obstruction, tuberculosis infections, pyrexia, urticaria, pneumonia, arthralgia, anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, angina pectoris, arrhythmias, atrial fibrillation, cardiac failure, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, optic neuritis, retinal hemorrhage, uveitis, bleeding, injection site reactions, elevated liver enzymes, hepatitis, alopecia totalis, anxiety, bipolar disorder, suicide attempt, nephrotic syndrome, renal failure, menstrual disorder, dermatitis, erythema nodosum, vasculitis, thrombophlebitis, systemic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, sarcoidosis, death"
21,CIMZIA,boxed warnings,"serious infections, hospitalization, death, tuberculosis, bacterial sepsis, invasive fungal infections, histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, Legionella, Listeria, lymphoma, malignancies, fatal"
22,CIMZIA,warnings and precautions,"serious infections, death, invasive fungal infections, lymphoma, heart failure, anaphylaxis, hepatitis B virus reactivation, demyelinating disease, cytopenias, pancytopenia, lupus-like syndrome, neurologic reactions, hematological reactions, autoimmunity"
23,KALYDECO,adverse reactions,"headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, increased hepatic enzymes, hypoglycemia, rhinitis, aspartate aminotransferase increased, bacteria in sputum, blood glucose increased, musculoskeletal chest pain, myalgia, sinus headache, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, acne, death"
24,KALYDECO,warnings and precautions,"Elevated transaminases, ALT or AST, transaminase elevations, increased transaminase levels, liver function tests abnormalities, ALT or AST of greater than 5 times the upper limit of normal (ULN), transaminase elevations, CYP3A inducers, decreased exposure of ivacaftor, diminished effectiveness, co-administration not recommended, cataracts, non-congenital lens opacities, pediatric patients, baseline and follow-up examinations."
25,FULYZAQ,adverse reactions,"Upper respiratory tract infection, bronchitis, cough, flatulence, increased bilirubin, nausea, back pain, arthralgia, urinary tract infection, nasopharyngitis, musculoskeletal pain, hemorrhoids, giardiasis, anxiety, increased alanine aminotransferase, abdominal distension, abdominal pain, acne, increased aspartate aminotransferase, increased conjugated bilirubin, increased unconjugated blood bilirubin, constipation, depression, dermatitis, dizziness, dry mouth, dyspepsia, gastroenteritis, herpes zoster, nephrolithiasis, pain in extremity, pollakiuria, procedural pain, seasonal allergy, sinusitis, decreased white blood cell count."
26,FULYZAQ,warnings and precautions,"infectious diarrhea, non-infectious diarrhea, death"
27,QUTENZA,adverse reactions,"pain, increase in blood pressure, erythema, pruritus, papules, edema, swelling, dryness, nasopharyngitis, bronchitis, sinusitis, nausea, vomiting, pruritus, hypertension, urticaria, paresthesia, dermatitis, hyperesthesia, excoriation, warmth, anesthesia, bruising, inflammation, exfoliation, peripheral edema, headache, burning sensation, peripheral sensory neuropathy, dizziness, dysgeusia, hypoesthesia, cough, throat irritation, abnormal skin odor"
28,QUTENZA,warnings and precautions,"coughing, sneezing, irritation of eyes, irritation of airway, transient increases in blood pressure, pain, increase in blood pressure, death"
29,GRANIX,adverse reactions,"Splenic Rupture, Acute Respiratory Distress Syndrome, Serious Allergic Reactions, Use in Patients with Sickle Cell Disease, Capillary Leak Syndrome, Potential for Tumor Growth Stimulatory Effects on Malignant Cells, bone pain, Leukocytosis, myalgia, headache, vomiting, Sweet's syndrome, cutaneous vasculitis, thrombocytopenia"
30,GRANIX,warnings and precautions,"Splenic rupture, death, Acute Respiratory Distress Syndrome (ARDS), death, Allergic reactions, angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria, Sickle cell crisis, death, Capillary Leak Syndrome, death."
31,COARTEM,adverse reactions,"headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, chills, fatigue, malaise, nausea, abdominal pain, diarrhea, sleep disorder, insomnia, palpitations, hepatomegaly, splenomegaly, anemia, pruritus, rash, vertigo, malaria, nasopharyngitis, Plasmodium falciparum infection, rhinitis, aspartate aminotransferase increased, eosinophilia, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, abscess, acrodermatitis, bronchitis, ear infection, gastroenteritis, helminthic infection, hookworm infection, impetigo, influenza, lower respiratory tract infection, oral herpes, pneumonia, respiratory tract infection, subcutaneous abscess, upper respiratory tract infection, urinary tract infection, alanine aminotransferase increased, hematocrit decreased, lymphocyte morphology abnormal, platelet count decreased, platelet count increased, white blood cell count decreased, white blood cell count increased, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, agitation, mood swings, hematuria, proteinuria, asthma, pharyngo-laryngeal pain, urticaria, anaphylaxis, angioedema, serious skin reactions, bullous eruption, death"
32,COARTEM,warnings and precautions,"prolongation of the QT Interval, death, QT prolongation, hypokalemia, hypomagnesemia, cardiac arrhythmias, bradycardia, severe cardiac disease, disturbances of electrolyte balance, long QT syndrome, sudden death, antipsychotics, antidepressants, macrolide antibiotics, fluoroquinolone antibiotics, imidazole, triazole antifungal agents, class IA antiarrhythmic agents, class III antiarrhythmic agents, CYP2D6 substrates, flecainide, imipramine, amitriptyline, clomipramine, antiretroviral medications, grapefruit juice, HIV protease inhibitors, non-nucleoside reverse transcriptase inhibitors, hormonal contraceptives, CYP2D6 inhibitors, hepatic impairment, renal impairment, Plasmodium vivax infection."
33,APTIOM,adverse reactions,"suicidal behavior, ideation, serious dermatologic reactions, drug reaction with eosinophilia and systemic symptoms (DRESS), multiorgan hypersensitivity, anaphylactic reactions, angioedema, hyponatremia, neurological adverse reactions, drug-induced liver injury, abnormal thyroid function tests, dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor, rash, dysarthria, asthenia, urinary tract infections, fall, memory impairment, nystagmus, depression, insomnia, cough, hypertension, decreases in hemoglobin, hematocrit, increases in total cholesterol, triglycerides, LDL, creatine phosphokinase, death"
34,APTIOM,warnings and precautions,"suicidal behavior, suicidal ideation, serious dermatologic reactions, drug reaction with eosinophilia and systemic symptoms (DRESS), anaphylactic reactions, angioedema, hyponatremia, neurological adverse reactions, dizziness, disturbance in gait and coordination, somnolence, fatigue, cognitive dysfunction, visual changes, death"
35,PROLIA,adverse reactions,"Hypocalcemia, death, serious infections, dermatologic adverse reactions, osteonecrosis of the Jaw, atypical Subtrochanteric and Diaphyseal Femoral Fractures, back pain, pain in extremity, musculoskeletal pain, hypercholesterolemia, cystitis, constipation, pancreatitis, anemia, angina pectoris, atrial fibrillation, vertigo, abdominal pain upper, flatulence, gastroesophageal reflux disease, edema peripheral, asthenia, upper respiratory tract infection, pneumonia, pharyngitis, herpes zoster, bone pain, myalgia, spinal osteoarthritis, sciatica, insomnia, rash, pruritus, erysipelas, cellulitis, ONJ, epidermal adverse events, dermal adverse events, pancreatitis, new malignancies, cataracts, drug-related hypersensitivity reactions, anaphylaxis, urticaria, facial swelling, erythema, musculoskeletal pain, severe cases, marked elevation in serum PTH, immunogenicity."
36,PROLIA,warnings and precautions,"hypersensitivity, anaphylactic reactions, hypocalcemia, osteonecrosis of the jaw, atypical femoral fractures, serious infections, skin infections, dermatologic reactions, dermatitis, rashes, eczema, severe bone pain, joint pain, muscle pain, suppression of bone turnover, death"
37,BLINCYTO,adverse reactions,"Cytokine Release Syndrome, Neurological Toxicities, Infections, Tumor Lysis Syndrome, Neutropenia, Febrile Neutropenia, Effects on Ability to Drive and Use Machines, Elevated Liver Enzymes, Leukoencephalopathy, Preparation and Administration Errors, pyrexia, headache, peripheral edema, febrile neutropenia, nausea, hypokalemia, tremor, rash, constipation, death, pneumonia, sepsis, device-related infection, encephalopathy, overdose, confusion, Staphylococcal bacteremia, anemia, thrombocytopenia, leukopenia, diarrhea, abdominal pain, vomiting, fatigue, chills, chest pain, cytokine release syndrome, other pathogen infections, bacterial infections, fungal infections, viral infections, increased alanine aminotransferase, increased aspartate aminotransferase, increased weight, hypomagnesemia, hyperglycemia, decreased appetite, hypophosphatemia, back pain, pain in extremity, bone pain, arthralgia, resting tremor, dizziness, insomnia, cough, dyspnea, rash, hypotension, hypertension, leukocytosis, lymphopenia, tachycardia, edema, cytokine storm, decreased immunoglobulins, increased blood bilirubin, increased gamma-glutamyl-transferase, increased liver enzymes, tumor lysis syndrome, hypoalbuminemia, encephalopathy, paresthesia, aphasia, convulsion, memory impairment, cognitive disorder, speech disorder, confusion, disorientation, capillary leak syndrome, hypersensitivity, bronchospasm."
38,BLINCYTO,boxed warnings,"Cytokine Release Syndrome, CRS, Neurological toxicities, death"
39,BLINCYTO,warnings and precautions,"Cytokine Release Syndrome, death, pyrexia, headache, nausea, asthenia, hypotension, increased alanine aminotransferase, increased aspartate aminotransferase, increased total bilirubin, disseminated intravascular coagulation, capillary leak syndrome, hemophagocytic lymphohistiocytosis, macrophage activation syndrome, Neurological Toxicities, encephalopathy, convulsions, speech disorders, disturbances in consciousness, confusion, disorientation, coordination and balance disorders, Infections, sepsis, pneumonia, bacteremia, opportunistic infections, catheter-site infections, Tumor Lysis Syndrome, death, Neutropenia, febrile neutropenia, Effects on Ability to Drive and Use Machines, seizures, Elevated Liver Enzymes, alanine aminotransferase, aspartate aminotransferase, gamma-glutamyl transferase, total blood bilirubin, Leukoencephalopathy, Preparation and Administration Errors, medication errors."
40,STENDRA,adverse reactions,"headache, flushing, nasal congestion, nasopharyngitis, back pain, upper respiratory infection, bronchitis, influenza, sinusitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, rash, dizziness, arthralgia, diarrhea, edema peripheral, fatigue, angina, unstable angina, deep vein thrombosis, palpitations, gastritis, gastroesophageal reflux disease, hypoglycemia, blood glucose increased, alanine aminotransferase increased, oropharyngeal pain, stomach discomfort, vomiting, muscle spasms, musculoskeletal pain, myalgia, pain in extremity, depression, insomnia, somnolence, vertigo, cough, dyspnea exertional, epistaxis, wheezing, pruritus, balanitis, erection increased, hematuria, nephrolithiasis, pollakiuria, urinary tract infection, electrocardiogram abnormal, gastroenteritis viral, Non-arteritic anterior ischemic optic neuropathy (NAION), death"
41,STENDRA,warnings and precautions,"hypotension, erection lasting greater than 4 hours, sudden loss of vision, Non Arteritic Ischemic Optic Neuropathy (NAION), sudden decrease or loss of hearing, cardiovascular risk, prolonged erection, priapism, anatomical deformation of the penis, effects on eye, sudden hearing loss, orthostatic signs and symptoms, increase in heart rate, dizziness, headache, effects on bleeding, sexually transmitted diseases"
42,XIAFLEX,adverse reactions,"tendon ruptures, serious injury, corporal rupture, penile fracture, severe penile hematoma, penile ecchymoses, penile detumescence, penile ""popping"" sound or sensation, edema peripheral, swelling of the injected hand, contusion, injection site hemorrhage, injection site reaction, pain in the injected extremity, penile swelling, penile pain, penile hematoma, penile ecchymoses, sudden penile detumescence, penile ""popping"" sound or sensation, severe penile hematoma, lymphadenopathy, skin laceration, lymph node pain, erythema, axillary pain, pruritus, vasovagal syncope, laceration, blood blister, injection site pain, injection site hematoma, axillary pain, ecchymosis, penile hemorrhage, penile bruising, penile edema, penile swelling, local swelling, scrotal swelling, injection site edema, penile ""popping"" sounds or sensations, detumescence, hematoma, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, nodule, suprapubic pain, penile blister, pruritus genital, penile ""snapping"", penile ""cracking"", penile ""popping"", severe penile hematoma, severe injection site hematoma."
43,XIAFLEX,boxed warnings,"corporal rupture, penile fracture, penile injury, penile ecchymoses, penile hematoma, sudden penile detumescence, penile ""popping"" sound or sensation, severe penile hematoma, death"
44,XIAFLEX,warnings and precautions,"Tendon rupture, serious injury to the injected finger/hand, corporal rupture (penile fracture), serious injury to the penis, hypersensitivity reactions, anaphylaxis, death, abnormal coagulation, ecchymosis, ligament damage, skin laceration, pulley rupture, complex regional pain syndrome (CRPS), sensory abnormality of the hand, penile ecchymoses, hematoma, sudden penile detumescence, penile ""popping"" sensation, severe penile hematoma, pruritus, allergic reactions, IgE-anti-drug antibodies, bleeding, injection site hemorrhage."
45,XEOMIN,adverse reactions,"Hypersensitivity, death, dysphagia, breathing difficulties, spread of effects from toxin, neck pain, muscle weakness, injection site pain, musculoskeletal pain, eyelid ptosis, dry eye, dry mouth, diarrhea, headache, visual impairment, dyspnea, nasopharyngitis, respiratory tract infection, eye disorders, eylid ptosis, eye swelling, nausea, flu-like symptoms, allergic dermatitis, localized allergic reactions, swelling, edema, erythema, pruritus, rash, herpes zoster, facial paresis, injection site hematoma, facial pain, injection site swelling, sensation of pressure, facial paresis (brow ptosis), muscle disorder, elevation of eyebrow, immunogenicity, eye swelling, myalgia, dysarthria."
46,XEOMIN,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death"
47,XEOMIN,warnings and precautions,"anaphylaxis, serum sickness, urticaria, soft tissue edema, dyspnea, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death"
48,GILOTRIF,adverse reactions,"Diarrhea, Bullous skin disorders, Exfoliative skin disorders, Interstitial lung disease, Hepatic toxicity, Keratitis, Rash, Dermatitis acneiform, Stomatitis, Paronychia, Dry skin, Decreased appetite, Nausea, Vomiting, Pruritus, Death, Dyspnea, Fatigue, Hypokalemia, Pulmonary toxicity, ILD-like adverse reactions, Sepsis, Pneumonia, Ventricular dysfunction, Diastolic dysfunction, Left ventricular dysfunction, Ventricular dilation, Stomatitis, Aphthous stomatitis, Mucosal inflammation, Mouth ulceration, Oral mucosa erosion, Mucosal erosion, Mucosal ulceration, Cheilitis, Paronychia, Nail infection, Nail bed infection, Cystitis, Epistaxis, Rhinorrhea, Weight decreased, Pyrexia, Conjunctivitis, Alanine aminotransferase increased, Hypokalemia, Aspartate aminotransferase increased, Pancreatitis"
49,GILOTRIF,warnings and precautions,"dehydration, renal failure, bullous skin disorders, exfoliative skin disorders, cutaneous reactions, interstitial lung disease, ILD, hepatic toxicity, hepatic impairment, keratitis, eye inflammation, ulcerative keratitis, embryofetal toxicity, fetal harm, abortions, death"
50,TREANDA,adverse reactions,"Myelosuppression, Infections, Anaphylaxis, Infusion Reactions, Tumor Lysis Syndrome, Skin Reactions, Other Malignancies, Extravasation injury, pyrexia, nausea, vomiting, asthenia, fatigue, malaise, weakness, dry mouth, somnolence, cough, constipation, headache, mucosal inflammation, stomatitis, worsening hypertension, hypertensive crisis, hypersensitivity, bilirubin elevations, increased bilirubin, AST elevation, ALT elevation, creatinine level changes, death, febrile neutropenia, pneumonia, hypokalemia, dehydration, tachycardia, abdominal pain, dyspepsia, gastroesophageal reflux disease, chills, edema peripheral, chest pain, infusion site pain, pain, catheter site pain, herpes zoster, upper respiratory tract infection, urinary tract infection, sinusitis, oral candidiasis, nasopharyngitis, weight decreased, anorexia, decreased appetite, hyperuricemia, back pain, arthralgia, pain in extremity, bone pain, headache, dizziness, dysgeusia, insomnia, anxiety, depression, dyspnea, pharyngolaryngeal pain, wheezing, nasal congestion, dry skin, night sweats, hyperhidrosis, hypotension, hyperglycemia, elevated creatinine, hyponatremia, hypocalcemia, hemolysis, taste disorder, atypical pneumonia, sepsis, herpes zoster, erythema, dermatitis, skin necrosis, anaphylaxis, phlebitis, pruritus, irritation, pain, swelling, pneumocystis jiroveci pneumonia, pneumonitis, SJS (Stevens-Johnson Syndrome), TEN (Toxic Epidermal Necrolysis)."
51,TREANDA,warnings and precautions,"myelosuppression, neutropenic sepsis, diffuse alveolar hemorrhage, thrombocytopenia, pneumonia, opportunistic infection, infection, pneumonia, sepsis, septic shock, anaphylaxis, infusion reactions, fever, chills, pruritus, rash, anaphylactic reactions, anaphylactoid reactions, tumor lysis syndrome, acute renal failure, skin reactions, rash, toxic skin reactions, bullous exanthema, toxic epidermal necrolysis, Stevens-Johnson syndrome, TEN, other malignancies, pre-malignant diseases, malignant diseases, myelodysplastic syndrome, myeloproliferative disorders, acute myeloid leukemia, bronchial carcinoma, extravasation injury, erythema, marked swelling, pain, embryo-fetal toxicity, fetal harm, resorptions, skeletal malformations, visceral malformations, decreased fetal body weights, death"
52,CHOLINE,adverse reactions,"injection site reaction, adverse reactions, death"
53,CHOLINE,warnings and precautions,"Imaging errors, allergic reactions, anaphylaxis, radiation risk, death"
54,ERWINAZE,adverse reactions,"Hypersensitivity reactions, death, Pancreatitis, Glucose intolerance, Thrombosis, hemorrhage, systemic hypersensitivity, hyperglycemia, transaminases abnormal, fever, local reactions, vomiting, nausea, hyperbilirubinemia, abdominal pain/discomfort, diarrhea"
55,ERWINAZE,warnings and precautions,"hypersensitivity reactions, anaphylaxis, pancreatitis, glucose intolerance, thrombosis, hemorrhage, death"
56,TRULICITY,adverse reactions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity reactions, Renal impairment, Severe Gastrointestinal Disease, death, Nausea, Diarrhea, Vomiting, Abdominal Pain, Decreased Appetite, Dyspepsia, Fatigue, constipation, flatulence, abdominal distension, gastroesophageal reflux disease, eructation, Heart Rate Increase, Tachycardia, Immunogenicity, Systemic hypersensitivity, Injection-site Reactions, PR Interval Prolongation, First Degree Atrioventricular (AV) Block, Amylase Increase, Lipase Increase"
57,TRULICITY,boxed warnings,"thyroid C-cell tumors, adenomas, carcinomas, medullary thyroid carcinoma, MTC, Multiple Endocrine Neoplasia syndrome type 2, mass in the neck, dysphagia, dyspnea, persistent hoarseness, death"
58,TRULICITY,warnings and precautions,"Thyroid C-cell Tumors, Thyroid C-cell adenomas, Thyroid C-cell carcinomas, Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, Acute renal failure, Worsening of chronic renal failure, Severe Gastrointestinal Disease."
59,ADREVIEW,adverse reactions,"hypersensitivity reactions, death, dizziness, rash, pruritis, flushing, headache, injection site hemorrhage"
60,ADREVIEW,warnings and precautions,"Hypersensitivity reactions, anaphylactic reactions, hypersensitivity, imaging errors, withdrawal signs and symptoms, benzyl alcohol toxicity, Gasping Syndrome, toxicity, hypotension, metabolic acidosis, kernicterus, death, radiation exposure, decreased quality of images, increased radiation exposure, renal impairment, thyroid accumulation, thyroid neoplasia, hypertension."
61,DOTAREM,adverse reactions,"NSF, hypersensitivity reactions, acute kidney injury, death, nausea, headache, injection site pain, injection site coldness, burning sensation, feeling cold, rash, somnolence, fatigue, dizziness, vomiting, pruritus, paresthesia, dysgeusia, pain in extremity, anxiety, hypertension, palpitations, oropharyngeal discomfort, serum creatinine increased, site inflammation, extravasation, warmth, bradycardia, tachycardia, arrhythmia, anaphylactoid reactions, cardiac arrest, respiratory arrest, cyanosis, pharyngeal edema, laryngospasm, bronchospasm, angioedema, conjunctivitis, ocular hyperemia, eyelid edema, lacrimation increased, hyperhidrosis, urticaria, coma, convulsion, syncope, presyncope, parosmia, tremor, muscle contracture, muscle weakness, diarrhea, salivary hypersecretion, malaise, fever, NSF, superficial phlebitis."
62,DOTAREM,boxed warnings,"Nephrogenic systemic fibrosis, NSF, fatal fibrosis, skin fibrosis, muscle fibrosis, internal organ fibrosis, death"
63,DOTAREM,warnings and precautions,"Nephrogenic Systemic Fibrosis, NSF, fatal, death, Hypersensitivity, Anaphylactoid reactions, Anaphylactic reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, death, Acute Kidney Injury, Extravasation, Injection Site Reactions"
64,PRADAXA,adverse reactions,"bleeding, gastrointestinal events, dyspepsia, nausea, upper abdominal pain, gastrointestinal hemorrhage, diarrhea, fatal bleeding, intracranial hemorrhage, hemorrhagic stroke, other intracranial hemorrhage, non-intracranial fatal bleed, gastritis-like symptoms, GERD, esophagitis, erosive gastritis, gastric hemorrhage, hemorrhagic gastritis, hemorrhagic erosive gastritis, gastrointestinal ulcer, drug hypersensitivity, urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock, angioedema, thrombocytopenia, esophageal ulcer, clinical myocardial infarction."
65,PRADAXA,boxed warnings,"thrombotic events, spinal/epidural hematoma, paralysis, death"
66,PRADAXA,warnings and precautions,"bleeding, fatal bleeding, thrombotic events, epidural hematoma, spinal hematoma, paralysis, thromboembolic events, major bleeding, neurological impairment, thromboembolic events, valve thrombosis, stroke, transient ischemic attack, myocardial infarction, post-operative pericardial effusions, hemodynamic compromise, deep venous thrombosis, pulmonary embolism"
67,ELIQUIS,adverse reactions,"thrombotic events, bleeding, spinal/epidural anesthesia or puncture, death, major bleeding, intracranial bleed, hemorrhagic stroke, gastrointestinal bleed, fatal bleeding, intracranial bleeding, non-intracranial bleeding, hypersensitivity reactions, syncope, epistaxis, hematoma, hematuria, menorrhagia, hemoptysis, rectal hemorrhage, gingival bleeding, thrombocytopenia, hypotension, gastrointestinal hemorrhage, liver function test abnormal, blood alkaline phosphatase increased, blood bilirubin increased, wound secretion, incision-site hemorrhage, operative hemorrhage, hemorrhagic anemia, hemorrhoidal hemorrhage, anal hemorrhage, traumatic hematoma, periorbital hematoma, muscle hemorrhage, vaginal hemorrhage, metrorrhagia, menometrorrhagia, genital hemorrhage, ecchymosis, skin hemorrhage, petechiae, conjunctival hemorrhage, retinal hemorrhage, eye hemorrhage, blood urine present, occult blood positive, red blood cells urine positive, injection-site hematoma, vessel puncture-site hematoma"
68,ELIQUIS,boxed warnings,"thrombotic events, spinal/epidural hematoma, death"
69,ELIQUIS,warnings and precautions,"bleeding, blood loss, stroke, thrombotic events, epidural hematoma, paralysis, neurological impairment, numbness, weakness, bowel dysfunction, bladder dysfunction, death"
70,ZERBAXA,adverse reactions,"Hypersensitivity reactions, Clostridium difficile-associated diarrhea, nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting, hypokalemia, ALT increased, AST increased, anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, tachycardia, angina pectoris, ileus, gastritis, abdominal distension, dyspepsia, flatulence, ileus paralytic, infusion site reactions, candidiasis, oropharyngeal, fungal urinary tract infection, increased serum gamma-glutamyl transpeptidase (GGT), increased serum alkaline phosphatase, positive Coombs test, hyperglycemia, hypomagnesemia, hypophosphatemia, ischemic stroke, renal impairment, renal failure, dyspnea, urticaria, venous thrombosis, death."
71,ZERBAXA,warnings and precautions,"decreased efficacy, serious hypersensitivity, anaphylactic reactions, clostridium difficile-associated diarrhea, CDAD, fatal colitis, death"
72,FERRIPROX,adverse reactions,"chromaturia, nausea, vomiting, abdominal pain, alanine aminotransferase increased, arthralgia, neutropenia, agranulocytosis, decreased plasma zinc concentrations, diarrhea, dyspepsia, weight increased, aspartate aminotransferase increased, neutrophil count decreased, increased appetite, decreased appetite, back pain, pain in extremity, arthropathy, headache, chromaturia (reddish/brown discoloration of the urine), thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritis, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension."
73,FERRIPROX,boxed warnings,"agranulocytosis, neutropenia, death"
74,FERRIPROX,warnings and precautions,"Agranulocytosis, Neutropenia, death, embryofetal toxicity"
75,DALVANCE,adverse reactions,"nausea, headache, diarrhea, vomiting, rash, pruritus, anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, blood alkaline phosphatase increased, international normalized ratio increased, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma, death"
76,DALVANCE,warnings and precautions,"hypersensitivity reactions, anaphylactic reactions, skin reactions, infusion-related reactions, Red-Man Syndrome, flushing, urticaria, pruritus, rash, hepatic effects, ALT elevations, Clostridium difficile-associated diarrhea, CDAD, fatal colitis, hypertoxin-producing strains, refractory infections, colectomy, drug-resistant bacteria, death"
77,ARCAPTA,adverse reactions,"cough, oropharyngeal pain, nasopharyngitis, headache, nausea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, hypersensitivity reactions, paradoxical bronchospasm, tachycardia/heart rate increase/palpitations, pruritus/rash, dizziness, death"
78,ARCAPTA,boxed warnings,"death, asthma-related death"
79,ARCAPTA,warnings and precautions,"death, asthma-related death, immediate hypersensitivity reactions, life-threatening paradoxical bronchospasm, cardiovascular effects, convulsive disorders, thyrotoxicosis, sensitivity to sympathomimetic drugs, hypokalemia, hyperglycemia"
80,CERDELGA,adverse reactions,"fatigue, headache, nausea, diarrhea, back pain, pain in extremities, upper abdominal pain, arthralgia, migraine, flatulence, oropharyngeal pain, dizziness, asthenia, cough, dyspepsia, gastroesophageal reflux disease, constipation, palpitations, rash"
81,CERDELGA,warnings and precautions,"cardiac arrhythmias, death, ECG Changes, PR prolongation, QTc prolongation, QRS prolongation, long QT syndrome, congestive heart failure, acute myocardial infarction, bradycardia, heart block, ventricular arrhythmia, Class IA antiarrhythmics, Class III antiarrhythmics"
82,GADAVIST,adverse reactions,"Nephrogenic Systemic Fibrosis, Hypersensitivity reactions, death, headache, nausea, dizziness, Dysgeusia, Feeling Hot, Injection site reactions, Vomiting, Rash, Pruritus, Erythema, Hypersensitivity/Anaphylactoid, Dyspnea, Paresthesia, loss of consciousness, convulsion, parosmia, tachycardia, palpitation, dry mouth, malaise, feeling cold, Cardiac arrest, anaphylactic shock, circulatory collapse, respiratory arrest, pulmonary edema, bronchospasm, cyanosis, oropharyngeal swelling, laryngeal edema, blood pressure increased, chest pain, angioedema, conjunctivitis, hyperhidrosis, cough, sneezing, burning sensation, pallor"
83,GADAVIST,boxed warnings,"Nephrogenic systemic fibrosis, NSF, fatal fibrosis, death, chronic kidney disease, GFR < 30 mL/min/1.73m2, acute kidney injury, impaired elimination, debilitating fibrosis, skin fibrosis, muscle fibrosis, internal organ fibrosis."
84,GADAVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis, NSF, Anaphylactic reactions, Hypersensitivity reactions, Cardiovascular reactions, Respiratory reactions, Cutaneous reactions, Death, Acute Kidney Injury, Extravasation, Injection Site Reactions, Overestimation of Extent of Malignant Disease"
85,ZYKADIA,adverse reactions,"Severe or Persistent Gastrointestinal Toxicity, Hepatotoxicity, Interstitial Lung Disease/Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, death, diarrhea, nausea, elevated transaminases, vomiting, abdominal pain, fatigue, decreased appetite, constipation, increased ALT, increased AST, serious adverse drug reactions, convulsion, pneumonia, ILD/pneumonitis, dyspnea, dehydration, hyperglycemia, nausea, fatal adverse reactions, respiratory failure, pneumothorax, gastric hemorrhage, general physical health deterioration, pulmonary tuberculosis, cardiac tamponade, sepsis, decreased appetite, neuropathy, vision disorder, prolonged QT interval, bradycardia, hemoglobin decreased, creatinine increased, glucose increased, phosphate decreased, lipase increased, bilirubin (total) increased."
86,ZYKADIA,warnings and precautions,"diarrhea, nausea, vomiting, abdominal pain, hepatotoxicity, interstitial lung disease, pneumonitis, QT interval prolongation, death, hyperglycemia, bradycardia, pancreatitis, embryofetal toxicity"
87,XALKORI,adverse reactions,"Hepatotoxicity, Interstitial Lung Disease, Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, death, vision disorders, diarrhea, nausea, vomiting, constipation, edema, elevated transaminases, upper respiratory infection, decreased appetite, dysgeusia, dyspnea, pulmonary embolism, septic shock, acute respiratory failure, diabetic ketoacidosis, ILD, alanine aminotransferase elevation, aspartate aminotransferase elevation, QTc prolongation, neutropenia, lymphopenia, hypophosphatemia, weight increased, pain in extremity, muscle spasm, dizziness, headache, syncope, weight decreased, rash, neuropathy, renal cyst, syncope, visual impairment, photopsia, blurred vision, vitreous floaters, sensory neuropathy, renal cysts, hypokalemia, hypophosphatemia, hepatic failure."
88,XALKORI,warnings and precautions,"Hepatotoxicity, liver testing, Interstitial Lung Disease, ILD, Pneumonitis, QT Interval Prolongation, electrocardiograms, electrolytes, Bradycardia, heart rate, blood pressure, Severe Visual Loss, visual field defect, vision loss, Embryofetal Toxicity, fetal harm, death"
89,BEPREVE,adverse reactions,"mild taste, taste, eye irritation, headache, nasopharyngitis, itching, body rash, swelling of lips, swelling of tongue, swelling of throat"
90,BEPREVE,warnings and precautions,"contamination, irritation, redness, absorption, death"
91,EDARBI,adverse reactions,"diarrhea, nausea, asthenia, fatigue, muscle spasm, dizziness, postural dizziness, cough, rash, pruritus, angioedema"
92,EDARBI,boxed warnings,"fetal toxicity, injury, death"
93,EDARBI,warnings and precautions,"hypotension, death, fetal toxicity, renal failure, oligohydramnios, neonatal morbidity, skull hypoplasia, anuria, hypotension, renal failure, death, renal function impairment, oliguria, progressive azotemia, acute renal failure, serum creatinine increase, blood urea nitrogen increase"
94,POTIGA,adverse reactions,"Retinal abnormalities, potential vision loss, urinary retention, skin discoloration, neuropsychiatric symptoms, dizziness, somnolence, QT interval effect, suicidal behavior, ideation, withdrawal seizures, death, fatigue, confusional state, vertigo, tremor, abnormal coordination, diplopia, disturbance in attention, memory impairment, asthenia, blurred vision, gait disturbance, aphasia, dysarthria, balance disorder, nausea, constipation, dyspepsia, influenza, weight increased, paresthesia, amnesia, dysphasia, anxiety, disorientation, psychotic disorder, dysuria, urinary hesitation, hematuria, chromaturia, increased appetite, hallucinations, myoclonus, peripheral edema, hypokinesia, dry mouth, dysphagia, hyperhidrosis, malaise, increased liver enzymes, rash, nystagmus, dyspnea, leukopenia, muscle spasms, alopecia, nephrolithiasis, syncope, neutropenia, thrombocytopenia, euphoric mood, renal colic, coma, encephalopathy."
95,POTIGA,boxed warnings,"vision loss, retinal abnormalities, retinal pigment dystrophies, damage to the photoreceptors, abnormal visual acuity, retinal pigmentary abnormalities, retinal pigmentary abnormalities, retinal abnormalities, retinal abnormalities, vision changes, death"
96,POTIGA,warnings and precautions,"Urinary retention, skin discoloration, retinal abnormalities, vision loss, confusional state, psychotic symptoms, hallucinations, dizziness, somnolence, QT prolongation, suicidal thoughts, suicidal behavior, death."
97,TUDORZA,adverse reactions,"Paradoxical bronchospasm, Worsening of narrow-angle glaucoma, Worsening of urinary retention, Immediate Hypersensitivity Reactions, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, anaphylaxis, angioedema, urticaria, rash, itching."
98,TUDORZA,warnings and precautions,"bronchospasm, paradoxical bronchospasm, narrow-angle glaucoma, urinary retention, hypersensitivity reactions, angioedema, anaphylaxis, milk proteins, death"
99,PROMACTA,adverse reactions,"Hepatic Decompensation, Hepatotoxicity, Thrombotic/Thromboembolic Complications, Cataracts, nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, anemia, pyrexia, fatigue, headache, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, alopecia, peripheral edema, hemorrhage, thrombotic/thromboembolic complications, oropharyngeal pain, increased AST, pharyngitis, back pain, paresthesia, rash, alopecia, musculoskeletal pain, blood alkaline phosphatase increased, dry mouth, hyperbilirubinemia, portal vein thromboses, abdominal pain, toothache, vitamin D deficiency, ALT increased, thrombotic microangiopathy with acute renal failure, death."
100,PROMACTA,boxed warnings,"hepatic decompensation, death"
101,PROMACTA,warnings and precautions,"Hepatotoxicity, liver enzyme elevations, hepatic decompensation, ascites, encephalopathy, indirect hyperbilirubinemia, abnormal serum liver tests, elevated bilirubin, liver injury, thrombotic events, thrombotic complications, thromboembolic complications, portal vein thrombosis, thrombotic complications, venous events, arterial events, Factor V Leiden, ATIII deficiency, antiphospholipid syndrome, cataracts"
102,INLYTA,adverse reactions,"diarrhea, hypertension, fatigue, decreased appetite, nausea, dysphonia, palmar-plantar erythrodysesthesia syndrome, weight decreased, vomiting, asthenia, constipation, hypothyroidism, cough, mucosal inflammation, arthralgia, stomatitis, dyspnea, abdominal pain, headache, pain in extremity, rash, proteinuria, dysgeusia, dry skin, dyspepsia, pruritus, alopecia, erythema, dizziness, upper abdominal pain, myalgia, dehydration, epistaxis, anemia, hemorrhoids, hematuria, tinnitus, lipase increased, glossodynia, pulmonary embolism, rectal hemorrhage, hemoptysis, deep vein thrombosis, retinal-vein occlusion/thrombosis, polycythemia, transient ischemic attack, hemoglobin decreased, lymphocytes (absolute) decreased, platelets decreased, white blood cells decreased, creatinine increased, bicarbonate decreased, hypocalcemia, ALP increased, hyperglycemia, lipase increased, amylase increased, ALT increased, AST increased, hypernatremia, hypoalbuminemia, hyperkalemia, hypoglycemia, hyponatremia, hypophosphatemia, hemoglobin increased, hypercalcemia."
103,INLYTA,warnings and precautions,"Hypertension, hypertensive crisis, arterial thromboembolic events, death, venous thromboembolic events, death, hemorrhagic events, death, cardiac failure, death, gastrointestinal perforation, fistula, death, hypothyroidism, thyroid dysfunction, reversible posterior leukoencephalopathy syndrome, proteinuria, elevation of liver enzymes, hepatic impairment, pregnancy"
104,NORTHERA,adverse reactions,"Supine Hypertension, Hyperpyrexia, Confusion, Ischemic heart disease exacerbation, Arrhythmias exacerbation, Congestive heart failure exacerbation, Headache, Dizziness, Nausea, Hypertension, Fatigue, Increased blood pressure, Falls, Urinary tract infections, Syncope."
105,NORTHERA,boxed warnings,"hypertension, supine hypertension, death"
106,NORTHERA,warnings and precautions,"supine hypertension, cardiovascular events, hyperpyrexia, confusion, neuroleptic malignant syndrome, fever, hyperthermia, muscle rigidity, involuntary movements, altered consciousness, mental status changes, ischemic heart disease exacerbation, arrhythmias exacerbation, congestive heart failure exacerbation, allergic reactions, bronchial asthma, FD&C Yellow No. 5 sensitivity, death"
107,JARDIANCE,adverse reactions,"Hypotension, Impairment in Renal Function, Hypoglycemia, Genital Mycotic Infections, Urinary Tract Infections, Increased Low-Density Lipoprotein Cholesterol (LDL-C), death"
108,JARDIANCE,warnings and precautions,"hypotension, renal impairment, hypoglycemia, genital mycotic infections, urinary tract infections, increased LDL-C, death"
109,FANAPT,adverse reactions,"dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, death"
110,FANAPT,boxed warnings,"death, cardiovascular events, heart failure, sudden death, infectious events, pneumonia"
111,FANAPT,warnings and precautions,"death, cerebrovascular-related adverse events, stroke, QT prolongation, arrhythmia, sudden death, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Hyperglycemia, diabetes mellitus, dyslipidemia, weight gain, Seizures, Orthostatic hypotension, Dizziness, tachycardia, syncope, Leukopenia, Neutropenia, Agranulocytosis, Hyperprolactinemia, Body Temperature Regulation, Dysphagia, Suicide, Priapism, Cognitive impairment, Motor impairment"
112,TANZEUM,adverse reactions,"Thyroid C-cell Tumors, Acute Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, death, Upper respiratory tract infection, Diarrhea, Nausea, Injection site reaction, Cough, Back pain, Arthralgia, Sinusitis, Influenza, vomiting, gastroesophageal reflux disease, dyspepsia, constipation, injection site hematoma, injection site erythema, injection site rash, injection site hypersensitivity, injection site hemorrhage, injection site pruritus, pneumonia, Atrial Fibrillation, Atrial Flutter, Appendicitis, Liver Enzyme Abnormalities, Gamma Glutamyltransferase Increase, Heart Rate Increase."
113,TANZEUM,boxed warnings,"thyroid C-cell tumors, medullary thyroid carcinoma, MTC, death"
114,TANZEUM,warnings and precautions,"Thyroid C-cell Tumors, MTC, pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, death"
115,EYLEA,adverse reactions,"Endophthalmitis, retinal detachments, increased intraocular pressure, thromboembolic events, conjunctival hemorrhage, eye pain, cataract, vitreous floaters, vitreous detachment, ocular hyperemia, corneal epithelium defect, detachment of the retinal pigment epithelium, injection site pain, foreign body sensation in eyes, lacrimation increased, vision blurred, intraocular inflammation, retinal pigment epithelium tear, injection site hemorrhage, eyelid edema, corneal edema, hypersensitivity, retinal tear, death."
116,EYLEA,warnings and precautions,"Endophthalmitis, retinal detachments, increases in intraocular pressure, arterial thromboembolic events, nonfatal stroke, nonfatal myocardial infarction, vascular death, death."
117,JEVTANA,adverse reactions,"Bone Marrow Suppression, Hypersensitivity Reactions, Gastrointestinal Adverse Reactions, Renal Failure, Use in Elderly Patients, Use in Patients with Hepatic Impairment, Embryo-Fetal Toxicity, neutropenia, anemia, leukopenia, thrombocytopenia, diarrhea, fatigue, nausea, vomiting, constipation, asthenia, abdominal pain, hematuria, back pain, anorexia, peripheral neuropathy, pyrexia, dyspnea, dysgeusia, cough, arthralgia, alopecia, death, infections, ventricular fibrillation, cerebral hemorrhage, arrhythmia, mucosal inflammation, urinary tract infection, weight decreased, dehydration, muscle spasms, dizziness, headache, hypotension, sepsis, septic shock, increased AST, increased ALT, increased bilirubin, gastritis, intestinal obstruction."
118,JEVTANA,boxed warnings,"Neutropenia, death, hypersensitivity, generalized rash, erythema, hypotension, bronchospasm."
119,JEVTANA,warnings and precautions,"neutropenia, febrile neutropenia, neutropenic infections, hypersensitivity reactions, nausea, vomiting, diarrhea, mortality related to diarrhea, gastrointestinal hemorrhage, gastrointestinal perforation, neutropenic enterocolitis, death, renal failure, fatal outcomes, elderly patients, fatal outcomes not related to disease progression, adverse reactions, hepatic impairment, fetal harm, embryo-fetal toxicity"
120,YERVOY,adverse reactions,"Immune-mediated enterocolitis, Immune-mediated hepatitis, Immune-mediated dermatitis, Immune-mediated neuropathies, Immune-mediated endocrinopathies, Other immune-mediated adverse reactions, ocular manifestations, fatigue, diarrhea, pruritus, rash, colitis, death, enterocolitis, hepatotoxicity, dermatitis, neuropathy, endocrinopathy, hypopituitarism, adrenal insufficiency, pneumonitis, meningitis, nephritis, eosinophilia, pericarditis, urticaria, large intestinal ulcer, esophagitis, acute respiratory distress syndrome, renal failure, infusion reaction, DRESS syndrome."
121,YERVOY,boxed warnings,"enterocolitis, hepatitis, dermatitis, toxic epidermal necrolysis, neuropathy, endocrinopathy, death"
122,YERVOY,warnings and precautions,"immune-mediated enterocolitis, diarrhea, fever, ileus, peritoneal signs, abdominal pain, mucus in stool, blood in stool, intestinal perforation, death, immune-mediated hepatitis, hepatotoxicity, AST elevation, ALT elevation, total bilirubin elevation, hepatic failure, hospitalization, immune-mediated endocrinopathies, hypopituitarism, adrenal insufficiency, hypogonadism, hypothyroidism, hyperthyroidism, Cushing's syndrome, adrenal crisis, immune-mediated dermatitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, rash, dermal ulceration, necrotic manifestations, bullous manifestations, hemorrhagic manifestations, immune-mediated neuropathies, Guillain-Barre syndrome, peripheral motor neuropathy, myasthenia gravis, immune-mediated ocular manifestations, nephritis, pneumonitis, meningitis, pericarditis, uveitis, iritis, hemolytic anemia, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy, encephalitis, myositis, polymyositis, ocular myositis"
123,FARXIGA,adverse reactions,"Hypotension, Impairment in Renal Function, Hypoglycemia, Genital Mycotic Infections, Increases in Low-Density Lipoprotein Cholesterol (LDL-C), Bladder Cancer, death, Female genital mycotic infections, Nasopharyngitis, Urinary tract infections, Back pain, Increased urination, Male genital mycotic infections, Nausea, Influenza, Dyslipidemia, Constipation, Discomfort with urination, Pain in extremity, Volume Depletion, Renal failure, Blood creatinine increase, Bone fractures, Hypersensitivity reactions, Increase in Hematocrit, Increase in Serum Inorganic Phosphorus, Increase in Low-Density Lipoprotein Cholesterol."
124,FARXIGA,warnings and precautions,"hypotension, renal impairment, hypoglycemia, genital mycotic infections, increased LDL-C, bladder cancer, death"
125,PICATO,adverse reactions,"local skin reactions, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, eyelid edema, eye pain, conjunctivitis, hypersensitivity, allergic contact dermatitis, herpes zoster, chemical conjunctivitis, corneal burn"
126,PICATO,warnings and precautions,"severe eye pain, chemical conjunctivitis, corneal burn, eyelid edema, eyelid ptosis, periorbital edema, vesiculation, pustulation, erosion, ulceration, erythema, crusting, swelling, anaphylaxis, allergic contact dermatitis, death"
127,PRISTIQ,adverse reactions,"Hypersensitivity, Suicidal Thoughts, Behaviors, Serotonin Syndrome, Elevated Blood Pressure, Abnormal Bleeding, Angle Closure Glaucoma, Activation of Mania/Hypomania, Discontinuation Syndrome, Seizure, Hyponatremia, Interstitial Lung Disease, Eosinophilic Pneumonia, death, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, specific male sexual function disorders, dry mouth, vomiting, fatigue, chills, feeling jittery, tremor, disturbance in attention, abnormal dreams, urinary hesitation, vision blurred, mydriasis, vertigo, tinnitus, dysgeusia, hot flush, anorgasmia, libido decreased, orgasm abnormal, ejaculation delayed, erectile dysfunction, ejaculation disorder, ejaculation failure, sexual dysfunction, asthenia, weight increased, liver function test abnormal, blood prolactin increased, musculoskeletal stiffness, syncope, convulsion, dystonia, depersonalization, bruxism, urinary retention, rash, alopecia, photosensitivity reaction, angioedema, tachycardia, myocardial ischemia, myocardial infarction, coronary occlusion, proteinuria, orthostatic hypotension, Stevens-Johnson syndrome."
128,PRISTIQ,boxed warnings,"suicidal thoughts, suicidal behaviors, worsening, emergence, death"
129,PRISTIQ,warnings and precautions,"suicidal thoughts, suicide, serotonin syndrome, elevated blood pressure, abnormal bleeding, angle closure glaucoma, activation of mania/hypomania, discontinuation syndrome, seizure, hyponatremia, interstitial lung disease, eosinophilic pneumonia, death"
130,STRIBILD,adverse reactions,"Lactic Acidosis, Severe Hepatomegaly with Steatosis, Severe Acute Exacerbations of Hepatitis B, New Onset or Worsening Renal Impairment, Bone Effects of Tenofovir DF, Immune Reconstitution Syndrome, death, Ocular icterus, Diarrhea, Flatulence, Nausea, Fatigue, Jaundice, Somnolence, Headache, Dizziness, Insomnia, Abnormal dreams, Rash, Suicidal ideation, Suicide attempt, depression, abdominal pain, dyspepsia, vomiting, fever, pain, nasopharyngitis, pneumonia, sinusitis, upper respiratory tract infection, arthralgia, back pain, myalgia, paresthesia, peripheral neuropathy, anxiety, increased cough, rhinitis, skin discoloration, hyperpigmentation, laboratory abnormalities, AST (>5.0 * ULN), ALT (>3.0 * ULN), Amylase(>2.0 * ULN), Creatine Kinase (>= 10.0 * ULN), Urine RBC (Hematuria) (> 75 RBC/HPF), bone fractures, Proteinuria, serum creatinine elevation, decreased estimated creatinine clearance, ALT (M: greater than 215 U per L; F: greater than 170 U per L), alkaline phosphatase (greater than 550 U per L), bilirubin (greater than 2.5 * ULN), serum glucose (less than 40 or greater than 250 mg per dL), glycosuria (greater than or equal to 3+), neutrophils (less than 750 per mm3), fasting cholesterol (greater than 240 mg per dL), fasting triglycerides (greater than 750 mg per dL), lipid abnormalities, allergic reaction, angioedema, lactic acidosis, hypokalemia, hypophosphatemia, dyspnea, pancreatitis, increased amylase, abdominal pain, hepatic steatosis, hepatitis, increased liver enzymes (most commonly AST, ALT gamma GT), rhabdomyolysis, osteomalacia, bone pain, fractures, muscular weakness, myopathy, acute renal failure, renal failure, acute tubular necrosis, Fanconi syndrome, proximal renal tubulopathy, interstitial nephritis, nephrogenic diabetes insipidus, renal insufficiency, increased creatinine, proteinuria, polyuria, asthenia."
131,STRIBILD,boxed warnings,"Lactic acidosis, severe hepatomegaly with steatosis, death, acute exacerbation of hepatitis B."
132,STRIBILD,warnings and precautions,"renal impairment, acute renal failure, Fanconi syndrome, lactic acidosis, severe hepatomegaly with steatosis, fatal cases, bone mineral density decreases, redistribution/accumulation of body fat, immune reconstitution syndrome, osteomalacia, proximal renal tubulopathy, mineralization defects, fat redistribution, immune reconstitution syndrome, death"
133,NULOJIX,adverse reactions,"PTLD, CNS PTLD, other malignancies, serious infections, JC virus-associated PML, polyoma virus nephropathy, anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, leukopenia, death."
134,NULOJIX,boxed warnings,"lymphoproliferative disorder, malignancies, serious infections, death"
135,NULOJIX,warnings and precautions,"PTLD, Post-Transplant Lymphoproliferative Disorder, CNS, neurological, cognitive, behavioral signs and symptoms, malignancies, UV light, sunlight, Progressive Multifocal Leukoencephalopathy, PML, bacterial infections, viral infections, fungal infections, protozoal infections, opportunistic infections, tuberculosis, Polyoma virus-associated nephropathy, kidney graft loss, liver transplant, Acute Rejection, Graft Loss, corticosteroid minimization, immunizations, live vaccines, death"
136,LUMIZYME,adverse reactions,"anaphylaxis, rash, pyrexia, flushing/feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension/increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, death"
137,LUMIZYME,boxed warnings,"anaphylaxis, hypersensitivity, immune-mediated reactions, cardiorespiratory failure, death"
138,LUMIZYME,warnings and precautions,"anaphylaxis, hypersensitivity reactions, anaphylactic shock, cardiac arrest, respiratory arrest, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, tongue swelling, lip swelling, periorbital edema, face edema, urticaria, chest discomfort, chest pain, wheezing, tachypnea, cyanosis, decreased oxygen saturation, convulsions, pruritus, rash, hyperhidrosis, nausea, dizziness, hypertension, increased blood pressure, flushing, feeling hot, erythema, pyrexia, pallor, peripheral coldness, restlessness, nervousness, headache, back pain, paresthesia, immune-mediated reactions, necrotizing skin lesions, type III immune-mediated reactions, inflammatory arthropathy, pyrexia, elevated erythrocyte sedimentation rate, nephrotic syndrome, membranous glomerulonephritis, acute cardiorespiratory failure, cardiac arrhythmia, sudden cardiac death, ventricular arrhythmias, bradycardia, antibody development, immunogenicity, IgG antibodies, inhibitory antibody activity, death"
139,EOVIST,adverse reactions,"Nephrogenic systemic fibrosis, death, hypersensitivity reactions, anaphylactic shock, hypotension, pharyngolaryngeal edema, urticaria, face edema, rhinitis, conjunctivitis, abdominal pain, hypoesthesia, sneezing, cough, pallor, tachycardia, restlessness, nausea, headache, feeling hot, dizziness, back pain, vomiting, blood pressure increased, injection site reactions (pain, burning, coldness, extravasation, irritation), dysgeusia, paresthesia, flushing, parosmia, pruritus (generalized, eye), rash, respiratory disorders (dyspnea, respiratory distress), fatigue, chest pain, vertigo, dry mouth, chills, feeling abnormal, tremor, akathisia, bundle branch block, palpitation, oral discomfort, salivary hypersecretion, maculopapular rash, hyperhidrosis, discomfort, malaise."
140,EOVIST,boxed warnings,"death, fatal, debilitating fibrosis, skin fibrosis, muscle fibrosis, internal organ fibrosis, chronic kidney disease, severe kidney disease, acute kidney injury, reduced renal function, glomerular filtration rate, NSF"
141,EOVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis, NSF, death, Hypersensitivity reactions, anaphylactoid/hypersensitivity reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, shock, Acute Kidney Injury, Extravasation, Injection Site Reactions, Interference with Laboratory Tests, Interference with Visualization of Liver Lesions"
142,BELEODAQ,adverse reactions,"Hematologic Toxicity, Infection, Hepatotoxicity, Tumor Lysis Syndrome, Gastrointestinal Toxicity, nausea, fatigue, pyrexia, anemia, vomiting, constipation, diarrhea, dyspnea, rash, peripheral edema, cough, thrombocytopenia, pruritus, chills, increased blood lactate dehydrogenase, decreased appetite, headache, infusion site pain, hypokalemia, prolonged QT, abdominal pain, hypotension, phlebitis, dizziness, pneumonia, increased creatinine, multi-organ failure, febrile neutropenia, death."
143,BELEODAQ,warnings and precautions,"Thrombocytopenia, leukopenia, neutropenia, lymphopenia, anemia, infection, death, hepatotoxicity, tumor lysis syndrome, embryo-fetal toxicity."
144,VICTRELIS,adverse reactions,"fatigue, anemia, nausea, headache, dysgeusia, death, anemia, neutropenia, pancytopenia, hypersensitivity, dry mouth, vomiting, diarrhea, chills, asthenia, decreased appetite, arthralgia, dizziness, insomnia, irritability, dyspnea exertional, alopecia, dry skin, rash, agranulocytosis, thrombocytopenia, mouth ulceration, stomatitis, pneumonia, sepsis, angioedema, urticaria, drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, exfoliative rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic skin eruption, toxicoderma"
145,VICTRELIS,warnings and precautions,"Embryofetal Toxicity, birth defects, fetal death, anemia, Neutropenia, Hypersensitivity, death"
146,VIMIZIM,adverse reactions,"Anaphylaxis, hypersensitivity reactions, pyrexia, vomiting, headache, nausea, abdominal pain, chills, fatigue, death"
147,VIMIZIM,boxed warnings,"anaphylaxis, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, death"
148,VIMIZIM,warnings and precautions,"anaphylaxis, hypersensitivity reactions, death, acute respiratory complications, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, peripheral edema, sleep apnea, airway patency, spinal cord compression, back pain, paralysis, urinary incontinence, fecal incontinence"
149,SIRTURO,adverse reactions,"mortality, death, QT Prolongation, Hepatotoxicity, Drug Interactions, nausea, arthralgia, headache, hemoptysis, chest pain, Anorexia, Transaminases Increased, Rash, Blood Amylase Increased, aminotransferase elevations, alanine aminotransferase, aspartate aminotransferase, tuberculosis-related, TB"
150,SIRTURO,boxed warnings,"Increased Mortality, death, QT Prolongation"
151,SIRTURO,warnings and precautions,"QT prolongation, ventricular arrhythmia, hepatotoxicity, death"
152,NEURACEQ,adverse reactions,"erythema, irritation, pain"
153,NEURACEQ,warnings and precautions,"errors, false positives, fatal event: death, radiation exposure, cancer"
154,COMETRIQ,adverse reactions,"Perforations, Fistula, Hemorrhage, Thromboembolic Events, Wound Complications, Hypertension, Osteonecrosis of the Jaw, Palmar-plantar erythrodysesthesia syndrome, Proteinuria, Reversible Posterior Leukoencephalopathy Syndrome, death"
155,COMETRIQ,boxed warnings,"perforations, fistulas, hemorrhage, death"
156,COMETRIQ,warnings and precautions,"Thrombotic Events, death, Wound Complications, Hypertension, Osteonecrosis of the Jaw, Palmar-plantar Erythrodysesthesia syndrome (PPES), Proteinuria, Reversible Posterior Leukoencephalopathy Syndrome, death, Hemorrhage, death, Perforations, Fistulas"
157,AFINITOR,adverse reactions,"Non-infectious pneumonitis, infections, angioedema, oral ulceration, renal failure, impaired wound healing, stomatitis, rash, fatigue, diarrhea, edema, abdominal pain, nausea, fever, asthenia, cough, headache, decreased appetite, death, hyperglycemia, dyspnea, pneumonitis, hypercholesterolemia, increased aspartate transaminase (AST), anemia, leukopenia, thrombocytopenia, lymphopenia, increased alanine transaminase (ALT), hypertriglyceridemia, lymphopenia, anemia, decreased potassium, thrombocytopenia, interstitial lung disease, lung infiltration, pulmonary fibrosis, acute renal failure, acute respiratory distress, cardiac arrest, hepatic failure, pneumonia, sepsis, pulmonary embolism, renal failure, hypoglycemia, myocardial infarction, congestive heart failure, sudden death, thrombotic events, pulmonary embolus, thrombosis, cellulitis, hyperglycemia, elevated creatinine, acute pancreatitis, cholecystitis, cholelithiasis, arterial thrombotic events, reflex sympathetic dystrophy."
158,AFINITOR,warnings and precautions,"Non-infectious pneumonitis, death, infections, death, angioedema, oral ulceration, renal failure, death, impaired wound healing, laboratory test alterations, death, vaccinations, embryo-fetal toxicity."
159,BREO,adverse reactions,"asthma-related death, death, asthma-related hospitalization, Candida albicans infection, pneumonia, immunosuppression, hypercorticism, adrenal suppression, reduction in bone mineral density, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, influenza, bronchitis, sinusitis, oropharyngeal pain, dysphonia, cough, back pain, arthralgia, pharyngitis, pyrexia, viral respiratory tract infection, extrasystoles, upper abdominal pain, respiratory tract infection, allergic rhinitis, supraventricular extrasystoles, ventricular extrasystoles, acute sinusitis, palpitations, tachycardia, hypersensitivity reactions, anaphylaxis, angioedema, rash, urticaria, muscle spasms, tremor, nervousness"
160,BREO,boxed warnings,"asthma-related death, death, asthma-related deaths, asthma-related hospitalization"
161,BREO,warnings and precautions,"asthma-related death, death, deterioration of Disease, acute episodes, pneumonia, death, immunosuppression, impaired adrenal function, death, hypercorticism, adrenal suppression, paradoxical bronchospasm, cardiovascular disorders, decrease in bone mineral density, glaucoma, cataracts, convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, hypokalemia, hyperglycemia, growth."
162,FIRAZYR,adverse reactions,"injection site reaction, pyrexia, transaminase increase, dizziness, rash, death"
163,FIRAZYR,warnings and precautions,"airway obstruction, death"
164,INVOKANA,adverse reactions,"Hypotension, Impairment in Renal Function, Hyperkalemia, Hypoglycemia, Genital Mycotic Infections, Hypersensitivity Reactions, Bone Fracture, Increases in Low-Density Lipoprotein (LDL-C), Female genital mycotic infections, Urinary tract infections, Increased urination, Male genital mycotic infections, Vulvovaginal pruritus, Thirst, Constipation, Nausea, Abdominal pain, Volume Depletion-Related Adverse Reactions, Falls, Fatigue, Loss of strength or energy, Pancreatitis, Hypersensitivity-related adverse reactions, Photosensitivity-related adverse reactions, Volume depletion-related adverse reactions, Impairment in Renal Function, Bone Fracture, Increases in Serum Potassium, Increases in Serum Magnesium, Increases in Serum Phosphate, Increases in Low-Density Lipoprotein Cholesterol (LDL-C), Increases in non-High-Density Lipoprotein Cholesterol (non-HDL-C), Increases in Hemoglobin, Decreases in Bone Mineral Density."
165,INVOKANA,warnings and precautions,"Hypotension, Impairment in Renal Function, Hyperkalemia, Hypoglycemia, Genital mycotic infections, Hypersensitivity reactions, Bone fracture, Increased LDL-C"
166,VORAXAZE,adverse reactions,"anaphylactic reactions, death, paraesthesias, flushing, nausea, vomiting, hypotension, headache, myelosuppression, mucositis, acute hepatitis, renal dysfunction, renal failure, paresthesia, blurred vision, diarrhea, hypersensitivity, hypertension, rash, throat irritation, throat tightness, tremor"
167,VORAXAZE,warnings and precautions,"Serious allergic reactions, anaphylactic reactions, death"
168,NESINA,adverse reactions,"nasopharyngitis, headache, upper respiratory tract infection, pancreatitis, hypersensitivity reactions, hypoglycemia, death"
169,NESINA,warnings and precautions,"acute pancreatitis, hypersensitivity, anaphylaxis, angioedema, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic effects, hepatic failure, fatal hepatic failure, hypoglycemia, arthralgia, severe joint pain, disabling arthralgia, macrovascular outcomes"
170,GILENYA,adverse reactions,"Bradyarrhythmia, Atrioventricular Blocks, Infections, Progressive multifocal leukoencephalopathy, Macular Edema, Posterior Reversible Encephalopathy Syndrome, Respiratory Effects, Liver Injury, death, Headache, liver transaminase elevation, diarrhea, cough, influenza, sinusitis, back pain, abdominal pain, pain in extremity, serum transaminase elevations, basal cell carcinoma, nausea, migraine, asthenia, alopecia, actinic keratosis, blood triglycerides increased, dyspnea, vision blurred, hypertension, lymphopenia, leukopenia, skin papilloma, dizziness, pneumonia, eczema, pruritus, ischemic strokes, hemorrhagic strokes, peripheral arterial occlusive disease, lymphomas."
171,GILENYA,warnings and precautions,"bradycardia, atrioventricular conduction, infections, progressive multifocal leukoencephalopathy (PML), macular edema, posterior reversible encephalopathy syndrome (PRES), decrease in pulmonary function tests (PFT), liver injury, fetal risk, blood pressure effects, death"
172,HALAVEN,adverse reactions,"neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, death"
173,HALAVEN,warnings and precautions,"Neutropenia, Peripheral Neuropathy, Embryo-Fetal Toxicity, QT Prolongation, death"
174,INTELENCE,adverse reactions,"Severe skin reactions, hypersensitivity reactions, rash, peripheral neuropathy, diarrhea, Stevens-Johnson syndrome, drug hypersensitivity reaction, erythema multiforme, death"
175,INTELENCE,warnings and precautions,"Stevens-Johnson syndrome, hypersensitivity reaction, toxic epidermal necrolysis, erythema multiforme, Drug Rash with Eosinophilia and Systemic Symptoms (DRESS), rash, liver transaminase elevations, rash with systemic symptoms, severe rash, fever, general malaise, fatigue, muscle or joint aches, blisters, oral lesions, conjunctivitis, facial edema, hepatitis, eosinophilia, angioedema, Grade 3 rash, Grade 4 rash, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", Immune Reconstitution Syndrome, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome, death."
176,AMYVID,adverse reactions,"headache, musculoskeletal pain, blood pressure increased, nausea, fatigue, injection site reaction, anxiety, back pain, claustrophobia, dizziness, feeling cold, insomnia, neck pain, infusion site rash, dysgeusia, pruritis, urticaria, flushing"
177,AMYVID,warnings and precautions,"image interpretation errors, false negatives, radiation risk, fatal event: death, errors, brain neuritic plaque density errors, image interpretation errors, clinical information errors, brain atrophy errors, motion artifacts errors, radiation exposure, cancer"
178,ULESFIA,adverse reactions,"ocular irritation, application site irritation, application site anesthesia, hypoesthesia, pain, pruritus, erythema, pyoderma, dryness, excoriation, paraesthesia, dermatitis, thermal burn, dandruff, rash, skin exfoliation"
179,ULESFIA,warnings and precautions,"Neonatal toxicity, gasping syndrome, severe metabolic acidosis, gasping respirations, progressive hypotension, seizures, central nervous system depression, intraventricular hemorrhage, death, eye irritation, eye exposure, eye irritation, contact dermatitis, allergic dermatitis, irritant dermatitis."
180,OTEZLA,adverse reactions,"diarrhea, nausea, headache, upper respiratory tract infection, tension headache, vomiting, nasopharyngitis, abdominal pain upper, weight decrease, frequent bowel movement, gastroesophageal reflux disease, dyspepsia, decreased appetite, migraine, cough, rash, fatigue, insomnia, back pain, depression, bronchitis, tooth abscess, folliculitis, sinus headache"
181,OTEZLA,warnings and precautions,"depression, suicidal thoughts, mood changes, weight loss, drug interactions, death"
182,ILARIS,adverse reactions,"infections, nasopharyngitis, diarrhea, influenza, headache, nausea, abdominal pain, injection site reactions, vertigo, musculoskeletal pain, bronchitis, gastroenteritis, pharyngitis, weight increased, rhinitis, tonsillitis, sinusitis, urinary tract infection, viral infection, pneumonia, varicella, measles, sepsis, otitis media, adenovirus, lymph node abscess, hypersensitivity, elevated transaminases, elevated bilirubin, death"
183,ILARIS,warnings and precautions,"serious infections, death, infections, upper respiratory tract infections, unusual infections, opportunistic infections, aspergillosis, atypical mycobacterial infections, cytomegalovirus, herpes zoster, tuberculosis, reactivation of latent tuberculosis, hypersensitivity reactions, malignancies, hypersensitivity, macrophage activation syndrome"
184,NATAZIA,adverse reactions,"Serious cardiovascular events, stroke, vascular events, liver disease, irregular uterine bleeding, nausea, breast tenderness, headache, myocardial infarction, ruptured ovarian cyst, deep vein thrombosis, focal nodular hyperplasia of the liver, uterine leiomyoma, acute cholecystitis, chronic acalculous cholecystitis, venous and arterial thromboembolic events (including pulmonary emboli, deep vein thrombosis, cerebral thrombosis, myocardial infarction, stroke), hypertension, gallbladder disease, hepatitis, hypersensitivity, fluid retention, hypertriglyceridemia, dizziness, chloasma, angioedema, erythema nodosum, erythema multiforme, gastrointestinal symptoms (abdominal pain), vulvovaginal candidiasis, death."
185,NATAZIA,boxed warnings,"cardiovascular events, serious cardiovascular events, fatal event: death"
186,NATAZIA,warnings and precautions,"Thromboembolic event, Vascular risks, Thrombotic event, Venous thromboembolism, Arterial thromboses, Strokes, Myocardial infarctions, Cerebrovascular events, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thromboembolic disorders, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic and hemorrhagic strokes, Thromboembolic disease, Thromboembolism, Thrombotic strokes, Hemorrhagic strokes, Arterial or venous thrombotic event, VTE, Arterial thrombotic event, Thromboembolic disease, Thromboembolism, Thrombotic"
187,DIFICID,adverse reactions,"nausea, vomiting, abdominal pain, gastrointestinal hemorrhage, anemia, neutropenia, death"
188,DIFICID,warnings and precautions,"angioedema, dyspnea, pruritus, rash, death"
189,ONFI,adverse reactions,"Somnolence, Sedation, Potentiation of Sedation, Withdrawal Symptoms, Serious Dermatological Reactions, Physical Dependence, Psychological Dependence, Suicidal Behavior, Ideation, Constipation, Pyrexia, Lethargy, Drooling, Vomiting, Dysphagia, Irritability, Fatigue, Upper respiratory tract infection, Pneumonia, Urinary tract infection, Bronchitis, Decreased appetite, Increased appetite, Ataxia, Psychomotor hyperactivity, Dysarthria, Aggression, Insomnia, Cough, Anemia, Eosinophilia, Leukopenia, Thrombocytopenia, Diplopia, Blurred vision, Abdominal distention, Hypothermia, Increased hepatic enzymes, Muscle spasms, Agitation, Anxiety, Apathy, Confusional state, Depression, Delirium, Delusion, Hallucination, Urinary retention, Aspiration, Respiratory depression, Rash, Urticaria, Angioedema, Facial edema, Lip edema."
190,ONFI,warnings and precautions,"Somnolence, Sedation, Withdrawal symptoms, Stevens-Johnson syndrome, Toxic epidermal necrolysis, Physical dependence, Psychological dependence, Suicidal behavior, Suicidal ideation, Death"
191,TECFIDERA,adverse reactions,"Anaphylaxis, Angioedema, Progressive multifocal leukoencephalopathy, Lymphopenia, Flushing, Abdominal pain, Diarrhea, Nausea, Vomiting, Pruritus, Rash, Albumin urine present, Erythema, Dyspepsia, Aspartate aminotransferase increased, Gastrointestinal events, Hepatic Transaminases, Eosinophilia"
192,TECFIDERA,warnings and precautions,"Anaphylaxis, angioedema, death, Progressive Multifocal Leukoencephalopathy (PML), lymphopenia, Flushing"
193,DYSPORT,adverse reactions,"Distant Spread of Toxin Effect, Lack of Interchangeability between Botulinum Toxin Products, Spread of Effects from Toxin, Dysphagia, Breathing Difficulties, Facial Anatomy in the Treatment of Glabellar Lines, Pre-existing Neuromuscular Disorders, Human Albumin, Intradermal Immune Reaction, muscular weakness, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, injection site pain, eye disorders, nasopharyngitis, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, urinary tract infection, dizziness, fall, depression, disturbance in attention, feeling abnormal, breathing difficulties, dyspnea, blurred vision, diplopia, reduced visual acuity, accommodation, muscle atrophy, blood present in urine, bronchitis, influenza, pharyngolaryngeal pain, cough, contact dermatitis, injection site swelling, injection site discomfort, vertigo, photophobia, influenza-like illness, amyotrophy, burning sensation, hypertonia, sensation of heaviness, antibody formation, binding antibodies, neutralizing antibodies."
194,DYSPORT,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death"
195,DYSPORT,warnings and precautions,"respiratory difficulties, speech difficulties, swallowing difficulties, asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death, dysphagia, facial asymmetry, inflammation, ptosis, dermatochalasis, dermal scarring, sebaceous skin, neuromuscular disorders, severe dysphagia, respiratory compromise, immune reaction"
196,ZYTIGA,adverse reactions,"Hypertension, Hypokalemia, Fluid Retention, Adrenocortical Insufficiency, Hepatotoxicity, fatigue, joint swelling or discomfort, edema, hot flush, diarrhea, vomiting, cough, dyspnea, urinary tract infection, contusion, anemia, elevated alkaline phosphatase, hypertriglyceridemia, lymphopenia, hypercholesterolemia, hyperglycemia, elevated AST, hypophosphatemia, elevated ALT, muscle discomfort, dyspepsia, urinary frequency, nocturia, fractures, arrhythmia, chest pain or chest discomfort, cardiac failure, myopathy, rhabdomyolysis, non-infectious pneumonitis, death."
197,ZYTIGA,warnings and precautions,"hypertension, hypokalemia, fluid retention, death, adrenocortical insufficiency, hepatotoxicity"
198,DUAVEE,adverse reactions,"muscle spasms, nausea, diarrhea, dyspepsia, abdominal pain upper, oropharyngeal pain, dizziness, neck pain, death"
199,DUAVEE,boxed warnings,"endometrial cancer, cardiovascular disorders, probable dementia, stroke, deep vein thrombosis, blood clots, heart attack, cancer of the lining of the uterus, breast cancer, cancer of the ovary, gallbladder problems, dementia, loss of vision, high blood pressure, increased fats in your blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of your mouth or tongue, worsening of other medical problems such as asthma, diabetes, epilepsy, migraines, a genetic problem called porphyria, lupus, muscle spasms, nausea, diarrhea, upset stomach, abdominal pain, throat pain, dizziness, neck pain, death"
200,DUAVEE,warnings and precautions,"venous thromboembolism, pulmonary embolism, stroke, retinal vascular thrombosis, endometrial cancer, breast cancer, ovarian cancer, gallbladder disease, loss of vision, severe hypertriglyceridemia, cholestatic jaundice, stroke, coronary heart disease, dementia, visual abnormalities, elevated blood pressure, hypertriglyceridemia, hepatic impairment, cholestatic jaundice, hypothyroidism, fluid retention, hypocalcemia, hereditary angioedema, exacerbation of asthma, diabetes mellitus, epilepsy, migraine, porphyria, systemic lupus erythematosus, hepatic hemangiomas, premenopausal use, laboratory test interactions, impaired glucose tolerance, death"
201,SAPHRIS,adverse reactions,"death, akathisia, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Metabolic Changes, Hypersensitivity Reactions, Orthostatic Hypotension, Syncope, Leukopenia, Neutropenia, Agranulocytosis, QT Interval Prolongation, Hyperprolactinemia, Seizures, Potential for Cognitive and Motor Impairment, Body Temperature Regulation, Suicide, Dysphagia, Constipation, Dry mouth, Oral hypoesthesia, Salivary hypersecretion, Vomiting, Fatigue, Irritability, Increased weight, Increased appetite, Dizziness, Extrapyramidal symptoms, Somnolence, Insomnia, Hypertension, Dysgeusia, Headache, Anxiety, Depression, Arthralgia, Pain in extremity, Muscle strain, Myalgia, Bradykinesia, Oromandibular dystonia, Muscle contractions involuntary, Muscle twitching, Musculoskeletal stiffness, Parkinsonism, Protrusion tongue, Resting tremor, Tremor, Edema peripheral, Dyspepsia, Dysmenorrhea, Anger, Galactorrhea, Dysarthria, Anemia, Thrombocytopenia, Temporary bundle branch block, Accommodation disorder, Swollen tongue, Idiosyncratic drug reaction, Hyponatremia, Diplopia, Vision blurred, Gastroesophageal reflux disease, Fall, Photosensitivity reaction, Enuresis, Choking, Oral ulcers, Blisters, Peeling/sloughing, Inflammation."
202,SAPHRIS,boxed warnings,"death, increased mortality, risk of death"
203,SAPHRIS,warnings and precautions,"cerebrovascular adverse events, stroke, transient ischemic attack, death, neuroleptic malignant syndrome, tardive dyskinesia, metabolic changes, hyperglycemia, dyslipidemia, weight gain, hypersensitivity reactions, anaphylaxis, angioedema, orthostatic hypotension, syncope, dizziness, tachycardia, bradycardia, leukopenia, neutropenia, agranulocytosis, QT prolongation, seizures, potential for cognitive and motor impairment, suicide, dysphagia, hyperprolactinemia, body temperature regulation"
204,DUREZOL,adverse reactions,"elevated intraocular pressure, optic nerve damage, visual acuity defects, field defects, posterior subcapsular cataract formation, secondary ocular infection, perforation of the globe, corneal edema, ciliary hyperemia, conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort, application site irritation, corneal pigmentation, corneal striae, episcleritis, eye pruritis, eyelid irritation, eyelid crusting, foreign body sensation, increased lacrimation, macular edema, sclera hyperemia, uveitis, blurred vision, headache, increased IOP, limbal hyperemia, conjunctival hyperemia, dry eye, iridocyclitis, anterior chamber flare, corneal edema, photophobia, reduced visual acuity, death"
205,DUREZOL,warnings and precautions,"IOP increase, glaucoma, damage to the optic nerve, defects in visual acuity, defects in fields of vision, cataracts, posterior subcapsular cataract formation, delayed healing, bleb formation, corneal thinning, scleral thinning, corneal perforations, bacterial infections, suppression of host response, secondary ocular infections, viral infections, exacerbation of viral infections, fungal infections, corneal fungal infections, fungal invasion, contact lens wear."
206,ZYDELIG,adverse reactions,"hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, severe cutaneous reactions, anaphylaxis, neutropenia, death, pneumonia, pyrexia, sepsis, febrile neutropenia, diarrhea, hepatotoxicity, nausea, cough, abdominal pain, chills, rash, vomiting, gastroesophageal reflux disease, stomatitis, headache, pain, nasal congestion, sepsis, bronchitis, sinusitis, urinary tract infection, arthralgia, lymphocyte count decreased, lymphocyte count increased, ALT increased, AST increased, GGT increased, hypertriglyceridemia, hyperglycemia, hypoglycemia, hyponatremia, fatigue, asthenia, peripheral edema, upper respiratory tract infection, dyspnea, night sweats, decreased appetite, insomnia, hemoglobin decreased, platelets decreased."
207,ZYDELIG,boxed warnings,"hepatic toxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, death"
208,ZYDELIG,warnings and precautions,"hepatotoxicity, death, severe diarrhea, colitis, pneumonitis, intestinal perforation, severe cutaneous reactions, anaphylaxis, neutropenia, embryo-fetal toxicity"
209,KALBITOR,adverse reactions,"hypersensitivity reactions, anaphylaxis, death, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, fatigue, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, erythema, pain, irritation, urticaria, bruising"
210,KALBITOR,boxed warnings,"anaphylaxis, hypersensitivity reactions, death"
211,KALBITOR,warnings and precautions,"anaphylaxis, death, chest discomfort, flushing, pharyngeal edema, pruritus, rhinorrhea, sneezing, nasal congestion, throat irritation, urticaria, wheezing, hypotension, rash"
212,ADCETRIS,adverse reactions,"Peripheral Neuropathy, Anaphylaxis, Infusion Reactions, Hematologic Toxicities, Serious Infections, Opportunistic Infections, Tumor Lysis Syndrome, Increased Toxicity in the Presence of Severe Renal Impairment, Increased Toxicity in the Presence of Moderate or Severe Hepatic Impairment, Hepatotoxicity, Progressive Multifocal Leukoencephalopathy, Pulmonary Toxicity, Serious Dermatologic Reactions, death"
213,ADCETRIS,boxed warnings,"PML, Progressive multifocal leukoencephalopathy, JC virus infection, death"
214,ADCETRIS,warnings and precautions,"peripheral neuropathy, neuropathy, sensory neuropathy, motor neuropathy, hypoesthesia, hyperesthesia, paresthesia, discomfort, burning sensation, neuropathic pain, weakness, anaphylaxis, infusion reactions, hematologic toxicities, neutropenia, thrombocytopenia, anemia, febrile neutropenia, serious infections, opportunistic infections, pneumonia, bacteremia, sepsis, septic shock, tumor lysis syndrome, hepatotoxicity, liver injury, transaminases elevation, bilirubin elevation, pulmonary toxicity, pneumonitis, interstitial lung disease, acute respiratory distress syndrome, dermatologic reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, embryo-fetal toxicity, fetal harm, death"
215,BESIVANCE,adverse reactions,"conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache"
216,BESIVANCE,warnings and precautions,"growth of resistant organisms, overgrowth of non-susceptible organisms, super-infection, death"
217,CLEVIPREX,adverse reactions,"hypotension, reflex tachycardia, headache, nausea, vomiting, acute renal failure, atrial fibrillation, myocardial infarction, cardiac arrest, syncope, dyspnea, death"
218,CLEVIPREX,warnings and precautions,"hypotension, reflex tachycardia, negative inotropic effects, exacerbate heart failure, rebound hypertension, death"
219,XTANDI,adverse reactions,"Seizure, asthenia/fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness/vertigo, spinal cord compression, cauda equina syndrome, paresthesia, mental impairment disorders, hypoesthesia, insomnia, anxiety, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, dysgeusia, restless legs syndrome, gynecomastia, dyspnea, exertional dyspnea, dyspnea at rest, non-pathological fracture, gynecomastia, neutropenia, thrombocytopenia, elevations in ALT, elevations in bilirubin, infections, falls, fall-related injuries, joint injuries, hematomas, hypertension, hypertensive crisis."
220,XTANDI,warnings and precautions,"seizure, death"
221,BOSULIF,adverse reactions,"anaphylactic shock, myelosuppression, gastrointestinal toxicity, diarrhea, fluid retention, hepatotoxicity, rash, nausea, thrombocytopenia, vomiting, abdominal pain, anemia, pyrexia, fatigue, increased alanine aminotransferase, headache, cough, increased aspartate aminotransferase, neutropenia, edema, arthralgia, decreased appetite, respiratory tract infection, nasopharyngitis, back pain, asthenia, pruritus, dizziness, dyspnea, QTcF interval greater than 500 milliseconds, febrile neutropenia, pericardial effusion, pericarditis, tinnitus, gastritis, acute pancreatitis, gastrointestinal hemorrhage, chest pain, pain, hepatotoxicity, abnormal hepatic function, liver injury, drug hypersensitivity, pneumonia, influenza, bronchitis, electrocardiogram QT prolonged, increased blood creatine phosphokinase, increased blood creatinine, hyperkalemia, dehydration, myalgia, dysgeusia, acute renal failure, renal failure, pleural effusion, acute pulmonary edema, respiratory failure, pulmonary hypertension, urticaria, acne, erythema multiforme, exfoliative rash, drug eruption"
222,BOSULIF,warnings and precautions,"Diarrhea, nausea, vomiting, abdominal pain, thrombocytopenia, anemia, neutropenia, ALT elevation, AST elevation, pericardial effusion, pleural effusion, pulmonary edema, peripheral edema, decline in estimated glomerular filtration rate, embryofetal toxicities, death"
223,CARBAGLU,adverse reactions,"Infections, vomiting, abdominal pain, pyrexia, tonsillitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, death"
224,CARBAGLU,warnings and precautions,"brain injury, death, hyperammonemia, injury, life-threatening, fatal"
225,SIMPONI,adverse reactions,"Serious Infections, Malignancies, death, Serious Infections, sepsis, pneumonia, cellulitis, abscess, opportunistic infections, tuberculosis (TB), invasive fungal infections, Malignancies, liver enzyme elevations, severe hepatic reactions, acute liver failure, Autoimmune Disorders, Autoantibodies, lupus-like syndrome, Administration Reactions, infusion reaction, rash, Immunogenicity, antibodies, Other Adverse Reactions, upper respiratory tract infection, viral infection, bronchitis, hypertension, rash, superficial fungal infection, sinusitis, lower respiratory tract infection (pneumonia), pyelonephritis, alanine aminotransferase increased, aspartate aminotransferase increased, neutrophil count decreased, dizziness, paresthesia, constipation, Neoplasm Benign and Malignant, melanoma, Immune System Disorders, serious systemic hypersensitivity reactions (including anaphylactic reaction), sarcoidosis, Respiratory, thoracic and mediastinal disorders, interstitial lung disease, Skin and subcutaneous tissue disorders, skin exfoliation, bullous skin reactions."
226,SIMPONI,boxed warnings,"serious infections, hospitalization, death, tuberculosis, TB, bacterial sepsis, invasive fungal, histoplasmosis, opportunistic infections, lymphoma, malignancies, fatal, disseminated disease, extrapulmonary disease, invasive fungal infections, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, Legionella, Listeria, signs and symptoms of infection, lymphoma, malignancies."
227,SIMPONI,warnings and precautions,"serious infections, death, invasive fungal infections, hepatitis B reactivation, malignancies, lymphoma, heart failure, demyelinating disease, exacerbation, new onset, hypersensitivity reactions, anaphylaxis"
228,BENLYSTA,adverse reactions,"Mortality, death, Serious Infections, Malignancy, Hypersensitivity Reactions, Anaphylaxis, Infusion Reactions, Depression, nausea, diarrhea, pyrexia, nasopharyngitis, bronchitis, insomnia, pain in extremity, migraine, pharyngitis, lupus nephritis, infections, cystitis, leukopenia, gastroenteritis viral, Fatal anaphylaxis"
229,BENLYSTA,warnings and precautions,"death, serious infections, fatal infections, progressive multifocal leukoencephalopathy, hypersensitivity reactions, anaphylaxis, depression, suicidality"
230,TOVIAZ,adverse reactions,"dry mouth, constipation, angina, chest pain, gastroenteritis, QT prolongation on ECG, dyspepsia, nausea, abdominal pain upper, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, blurred vision, palpitations, hypersensitivity reactions, angioedema with airway obstruction, face edema, dizziness, headache, somnolence, urticaria, pruritus"
231,TOVIAZ,warnings and precautions,"Angioedema, face angioedema, lips angioedema, tongue angioedema, larynx angioedema, urinary retention, gastrointestinal motility decreased, severe constipation, narrow-angle glaucoma, somnolence, myasthenia gravis, death"
232,ENTEREG,adverse reactions,"dyspepsia,"
233,ENTEREG,boxed warnings,"myocardial infarction, death"
234,ENTEREG,warnings and precautions,"myocardial infarctions, death, abdominal pain, nausea, vomiting, diarrhea, severe hepatic impairment, end-stage renal disease, complete gastrointestinal obstruction, surgery for correction of complete bowel obstruction, pancreatic anastomosis, gastric anastomosis"
235,VIZAMYL,adverse reactions,"flushing, headache, increased blood pressure, nausea, dizziness"
236,VIZAMYL,warnings and precautions,"flushing, dyspnea, death"
237,AMPYRA,adverse reactions,"Seizures, Anaphylaxis, Urinary Tract Infections, death, Urinary tract infection, Insomnia, Dizziness, Headache, Nausea, Asthenia, Back pain, Balance disorder, Multiple sclerosis relapse, Paresthesia, Nasopharyngitis, Constipation, Dyspepsia, Pharyngolaryngeal pain."
238,AMPYRA,warnings and precautions,"seizures, death, anaphylaxis"
